Expanding the concept of neuroprotection for acute ischemic stroke: The pivotal roles of reperfusion and the collateral circulation

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

This review surveys the efforts taken to achieve clinically efficacious protection of the ischemic brain and underscores the necessity of expanding our purview to include the essential role of cerebral perfusion and the collateral circulation. We consider the development of quantitative strategies to measure cerebral perfusion at the regional and local levels and the application of these methods to elucidate flow-related thresholds of ischemic viability and to characterize the ischemic penumbra. We stress that the modern concept of neuroprotection must consider perfusion, the necessary substrate upon which ischemic brain survival depends. We survey the major mechanistic approaches to neuroprotection and review clinical neuroprotection trials, focusing on those phase 3 multicenter clinical trials for acute ischemic stroke that have been completed or terminated. We review the evolution of thrombolytic therapies; consider the lessons learned from the initial, negative multicenter trials of endovascular therapy; and emphasize the highly successful positive trials that have finally established a clinical role for endovascular clot removal. As these studies point to the brain's collateral circulation as key to successful reperfusion, we next review the anatomy and pathophysiology of collateral perfusion as it relates to ischemic infarction, as well as the molecular and genetic influences on collateral development. We discuss the current MR and CT-based diagnostic methods for assessing the collateral circulation and the prognostic significance of collaterals in ischemic stroke, and we consider past and possible future therapeutic directions.

Original languageEnglish (US)
Pages (from-to)46-77
Number of pages32
JournalProgress in Neurobiology
Volume145-146
DOIs
StatePublished - Oct 1 2016

Fingerprint

Collateral Circulation
Reperfusion
Perfusion
Stroke
Multicenter Studies
Brain
Phase III Clinical Trials
Thrombolytic Therapy
Infarction
Molecular Biology
Anatomy
Clinical Trials
Neuroprotection
Therapeutics
Surveys and Questionnaires

Keywords

  • Albumin
  • Brain
  • Cerebral ischemia
  • Collateral circulation
  • Collaterals
  • Computed tomography
  • Endovascular intervention
  • Infarction
  • Ischemic stroke
  • Magnetic resonance imaging
  • Multicenter clinical trial
  • Neuroprotection
  • Nitric oxide
  • Penumbra
  • Perfusion
  • Recanalization
  • Reperfusion
  • Thrombolysis

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

@article{44c4219c078748f68cab3ce4f21fc33a,
title = "Expanding the concept of neuroprotection for acute ischemic stroke: The pivotal roles of reperfusion and the collateral circulation",
abstract = "This review surveys the efforts taken to achieve clinically efficacious protection of the ischemic brain and underscores the necessity of expanding our purview to include the essential role of cerebral perfusion and the collateral circulation. We consider the development of quantitative strategies to measure cerebral perfusion at the regional and local levels and the application of these methods to elucidate flow-related thresholds of ischemic viability and to characterize the ischemic penumbra. We stress that the modern concept of neuroprotection must consider perfusion, the necessary substrate upon which ischemic brain survival depends. We survey the major mechanistic approaches to neuroprotection and review clinical neuroprotection trials, focusing on those phase 3 multicenter clinical trials for acute ischemic stroke that have been completed or terminated. We review the evolution of thrombolytic therapies; consider the lessons learned from the initial, negative multicenter trials of endovascular therapy; and emphasize the highly successful positive trials that have finally established a clinical role for endovascular clot removal. As these studies point to the brain's collateral circulation as key to successful reperfusion, we next review the anatomy and pathophysiology of collateral perfusion as it relates to ischemic infarction, as well as the molecular and genetic influences on collateral development. We discuss the current MR and CT-based diagnostic methods for assessing the collateral circulation and the prognostic significance of collaterals in ischemic stroke, and we consider past and possible future therapeutic directions.",
keywords = "Albumin, Brain, Cerebral ischemia, Collateral circulation, Collaterals, Computed tomography, Endovascular intervention, Infarction, Ischemic stroke, Magnetic resonance imaging, Multicenter clinical trial, Neuroprotection, Nitric oxide, Penumbra, Perfusion, Recanalization, Reperfusion, Thrombolysis",
author = "Myron Ginsberg",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.pneurobio.2016.09.002",
language = "English (US)",
volume = "145-146",
pages = "46--77",
journal = "Progress in Neurobiology",
issn = "0301-0082",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Expanding the concept of neuroprotection for acute ischemic stroke

T2 - The pivotal roles of reperfusion and the collateral circulation

AU - Ginsberg, Myron

PY - 2016/10/1

Y1 - 2016/10/1

N2 - This review surveys the efforts taken to achieve clinically efficacious protection of the ischemic brain and underscores the necessity of expanding our purview to include the essential role of cerebral perfusion and the collateral circulation. We consider the development of quantitative strategies to measure cerebral perfusion at the regional and local levels and the application of these methods to elucidate flow-related thresholds of ischemic viability and to characterize the ischemic penumbra. We stress that the modern concept of neuroprotection must consider perfusion, the necessary substrate upon which ischemic brain survival depends. We survey the major mechanistic approaches to neuroprotection and review clinical neuroprotection trials, focusing on those phase 3 multicenter clinical trials for acute ischemic stroke that have been completed or terminated. We review the evolution of thrombolytic therapies; consider the lessons learned from the initial, negative multicenter trials of endovascular therapy; and emphasize the highly successful positive trials that have finally established a clinical role for endovascular clot removal. As these studies point to the brain's collateral circulation as key to successful reperfusion, we next review the anatomy and pathophysiology of collateral perfusion as it relates to ischemic infarction, as well as the molecular and genetic influences on collateral development. We discuss the current MR and CT-based diagnostic methods for assessing the collateral circulation and the prognostic significance of collaterals in ischemic stroke, and we consider past and possible future therapeutic directions.

AB - This review surveys the efforts taken to achieve clinically efficacious protection of the ischemic brain and underscores the necessity of expanding our purview to include the essential role of cerebral perfusion and the collateral circulation. We consider the development of quantitative strategies to measure cerebral perfusion at the regional and local levels and the application of these methods to elucidate flow-related thresholds of ischemic viability and to characterize the ischemic penumbra. We stress that the modern concept of neuroprotection must consider perfusion, the necessary substrate upon which ischemic brain survival depends. We survey the major mechanistic approaches to neuroprotection and review clinical neuroprotection trials, focusing on those phase 3 multicenter clinical trials for acute ischemic stroke that have been completed or terminated. We review the evolution of thrombolytic therapies; consider the lessons learned from the initial, negative multicenter trials of endovascular therapy; and emphasize the highly successful positive trials that have finally established a clinical role for endovascular clot removal. As these studies point to the brain's collateral circulation as key to successful reperfusion, we next review the anatomy and pathophysiology of collateral perfusion as it relates to ischemic infarction, as well as the molecular and genetic influences on collateral development. We discuss the current MR and CT-based diagnostic methods for assessing the collateral circulation and the prognostic significance of collaterals in ischemic stroke, and we consider past and possible future therapeutic directions.

KW - Albumin

KW - Brain

KW - Cerebral ischemia

KW - Collateral circulation

KW - Collaterals

KW - Computed tomography

KW - Endovascular intervention

KW - Infarction

KW - Ischemic stroke

KW - Magnetic resonance imaging

KW - Multicenter clinical trial

KW - Neuroprotection

KW - Nitric oxide

KW - Penumbra

KW - Perfusion

KW - Recanalization

KW - Reperfusion

KW - Thrombolysis

UR - http://www.scopus.com/inward/record.url?scp=84994017881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994017881&partnerID=8YFLogxK

U2 - 10.1016/j.pneurobio.2016.09.002

DO - 10.1016/j.pneurobio.2016.09.002

M3 - Review article

C2 - 27637159

AN - SCOPUS:84994017881

VL - 145-146

SP - 46

EP - 77

JO - Progress in Neurobiology

JF - Progress in Neurobiology

SN - 0301-0082

ER -